Cuprina Holdings

Cuprina Holdings is a Singapore-based biomedical and biotechnology company focused on harnessing entomology-driven solutions for healthcare, agriculture, and waste management. Its primary medical innovation is MEDIFLY, a bio-dressing therapy utilizing live, medical-grade Lucilia cuprina maggots. These products are designed to clean wound beds and treat chronic wounds, offering a clinically effective and cost-conscious alternative to traditional debridement methods. By integrating biological insights into industrial processes, the company also explores broader applications for its technologies in sustainable development and circular economy solutions.

The company serves healthcare providers, clinics, and hospitals by providing end-to-end wound care solutions intended to improve patient quality of life and reduce the frequency of amputations. Their medical products have demonstrated significant clinical efficacy in local studies, including high rates of limb salvage and wound closure for complex patient populations. Through its leadership in biotechnology and insect-based applications, Cuprina addresses critical medical challenges while simultaneously expanding its capabilities into urban farming and sustainable resource management, aiming to build a future-fit organization that benefits both communities and the planet.